JBSAY yields 9.88% · JNJ yields 2.13%● Live data
📍 JBSAY pulled ahead of the other in Year 1
Combined, JBSAY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JBSAY + JNJ for your $10,000?
JBS S.A., a food company, processes and trades in animal protein worldwide. It offers beef, pork, chicken, and lamb products and by-products; food products; pet food and concentrates; and bresaola. The company also produces and commercializes steel cans, plastic resins, soap bases and bars, biodiesel, glycerin, fatty acid, collagen, and wrapper, as well as wet blue, semi-finished, and finished leather products; manages industrial residue; purchases and sells soybeans; and produces, cogenerates, and commercializes electric power. In addition, it is involved in tallow, palm oil, caustic soda, stearin, transportation, dog biscuits, hygiene and personal care, and sausage casings business; the operation of distribution centers and harbors; and the provision of cattle fattening, transportation, logistics, warehousing, and waste management and recycling services. Further, the company trades in cooked frozen meat; and operates Mercado da Carne store that provides beef and related items. It offers its products under the 1953, Doriana, Friboi, Massa Leve, Maturatta, Seara, Seara Gourmet, Swift, Angus Friboi, Anglo, Big Frango, Bordon, Confiança, delicate, Do Chef, Frangosul, Frigor Hans, LeBon, Reserva Friboi, Rezende, 1855, Incrível Seara, 5 Star, Aspen Ridge, Plumrose, Gold'n Plump, Just Bared Chicken, La Herencia, Moy Park, Pilgrim's, Primo, Rigamonti, and Swift Black. The company was formerly known as Friboi Ltda. JBS S.A. was founded in 1953 and is headquartered in São Paulo, Brazil.
Full JBSAY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.